中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
BOC-(R)-3-氨基-3-(2,3-二氯苯基)-丙酸 |
(R)-3-((tert-Butoxycarbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid |
500788-91-0 |
C14H17Cl2NO4 |
|
BOC-(R)-3-氨基-2-羟甲基丁酸 |
(R)-3-((tert-butoxycarbonyl)amino)-2-(hydroxymethyl)propanoic acid |
1190870-93-9 |
C9H17NO5 |
|
BOC-(R)-3-噻吩基甘氨酸 |
(R)-2-(tert-butoxycarbonylamino)-2-(thiophen-3-yl)acetic acid |
33130-97-1 |
C11H15NO4S |
|
BOC-(R)-2-甲氧基苯基甘氨酸 |
(R)-2-((tert-butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid |
1217786-73-6 |
C14H19NO5 |
|
BOC-(R)-2-(2-噻吩基)-甘氨酸 |
R-tert-butoxyformamido-(2-thienyl)acetic acid |
74562-03-1 |
C11H15NO4S |
|
BOC-(2S,4S)-4-氨基-1-FMOC-吡咯烷-2-羧酸 |
4-N-tert-butyloxycarbonylamino-N-9-fluorenylmethyloxycarbonyl-L-cis-proline |
221352-74-5 |
C25H28N2O6 |
|
BOC-(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-METHYLBENZYL)PYRROLIDINE-2-CARBOXYLICACID(2S,4R)-1-(叔丁氧基羰基)-4-(4-甲基苄基)吡咯烷-2-羧酸 |
Boc-(R)-4-(4-methylbenzyl)-L-proline |
959581-21-6 |
C18H25NO4 |
|
BOC-(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLICACID(2S,4R)-1-(叔丁氧基羰基)-4-(3-氟苄基)吡咯烷-2-羧酸MFCD06659389 |
(2S,4R)-1-(tert-butoxycarbonyl)-4-(3-fluorobenzyl)pyrrolidine-2-carboxylic acid |
959579-74-9 |
C17H22FNO4 |
|
BOC-(2S,3R)-3-氨基-2-羟基-4-(4-硝基苯基)丁酸 |
(2S,3R)-3-(Boc-amino)-2-hydroxy-4-(4-nitrophenyl)butyric acid |
112898-24-5 |
C15H20N2O7 |
|
BNPS-粪臭素 |
BNPS-Skatole |
27933-36-4 |
C15H11BrN2O2S |
|
BMS470539二盐酸盐 |
(2S)-2-Amino-N-[(2R)-1-(4-butanoyl-4-phenylpiperidin-1-yl)-3-(4-methoxyphenyl)-1-oxopropan-2-yl]-3-(3-methylimidazol-4-yl)propanamide |
457893-92-4 |
C32H41N5O4 |
|
BMS202(PD-1/PD-L1抑制剂2) |
BMS-202 |
1675203-84-5 |
C25H29N3O3 |
|
BMS-687453抑制剂 |
BMS-687453 |
1000998-59-3 |
C22H21ClN2O6 |
|
BMS 754807; (2S)-1-[4-[(5-环丙基-1H-吡唑-3-基)氨基]吡咯并[2,1-f][1,2,4]三嗪-2-基]-N-(6-氟-3-吡啶基)-2-甲基-2-吡咯烷甲酰胺 |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
|
BMS 740808; 1-(3-氨基-1,2-苯并[d]异噁唑-5-基)-3-三氟甲基-6-[4-[2-[[(3R)-3-羟基-1-吡咯烷基]甲基]苯基]苯基]-1,4,5,6-四氢-7H-吡唑并[3,4-c]吡啶-7-酮 |
BMS-740808 |
280118-23-2 |
C31H27F3N6O3 |
|
BMS 554417; 4-[2-[4-[[(2S)-2-(3-氯苯基)-2-羟基乙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-7-甲基-1H-苯并咪唑-5-基]-1-哌嗪丙腈 |
BMS-554417 |
468741-42-6 |
C28H30ClN7O2 |
|
BMS 378806; 1-[(2R)-4-苯甲酰基-2-甲基-1-哌嗪基]-2-(4-甲氧基-1H-吡咯并[2,3-b]吡啶-3-基)-1,2-乙二酮 |
4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine |
357263-13-9 |
C22H22N4O4 |
|
BMIK 双(1-甲基-2-咪唑基)甲酮 |
bis(N-methylimidazol-2-yl)keton |
62366-40-9 |
C9H10N4O |
|
BM15766硫酸盐 |
4-[2-[4-[3-(4-Chlorophenyl)-2-propenyl]-1-piperazinyl]ethyl]benzoic acid sulfate |
86621-94-5 |
C22H27ClN2O6S |
|
BLU-667(拉西替尼) |
Pralsetinib |
2097132-94-8 |
C27H32FN9O2 |
|
BLU-554中间体 |
2-chloro-6-(3,5-dimethoxyphenyl)quinazoline |
1538605-05-8 |
C16H13ClN2O2 |
|
BLI489水合物 |
BLI-489 |
623564-40-9 |
C13H10N3O4S*Na |
|
BL-1021盐酸盐 |
BL-1021 hydrochloride |
1002331-76-1 |
C23H28N2O*ClH |
|
BIXNHE1抑制剂 |
4-(1-acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide;hydrochloride |
1422252-46-7 |
C16H19F3N4O2*ClH |
|
BIX01294TrihydrochlorideHydrateBIX01294三盐酸盐水合物 |
N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine trihydrochloride |
1392399-03-9 |
C28H41Cl3N6O2 |
|
BISTHFHNS衍生物3 |
2,5-dioxopyrrolidin-1-yl ((3R,3aR,6aS)-hexahydrofuro[2,3-b]furan-3-yl) carbonate |
799241-86-4 |
C11H13NO7 |
|
BIS-四聚乙二醇-磺酸 |
Bis-PEG4-sulfonic acid |
1807539-08-7 |
C10H22O10S2 |
|
BIS-MUP,二(4-甲基伞形酮)磷酸酯 |
Di(4-methylcumarin-7-yl)phosphat |
51379-07-8 |
C20H15O8P |
|
BIP抑制剂(HA15) |
HA15 |
1609402-14-3 |
C23H22N4O3S2 |
|
BIOTIN-六聚乙二醇-叠氮 |
N-(20-azido-3,6,9,12,15,18-hexaoxaicosyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide |
1085938-09-5 |
C24H44N6O8S |
|
BIOTIN-三聚乙二醇 |
5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]pentanamide |
289714-02-9 |
C16H29N3O5S |
|
BIIE 246 |
(S)-N<sup>2</sup>-[[1-[2-[4-[(R,S)-5,11-dihydro6(6h)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxo-ethyl]-cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamid |
246146-55-4 |
C49H57N11O6 |
|
BIIB-024; 6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺 |
(R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide |
1096708-71-2 |
C17H12Cl2F3N7O2S |
|
BIIB 021; 6-氯-9-[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]-9H-嘌呤-2-胺 |
BIIB021 |
848695-25-0 |
C14H15ClN6O |
|
BIBF1120中间体 |
methyl (E)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1168150-46-6 |
C18H15NO4 |
|
BI-847325,MEK和极光激酶(AK)的ATP竞争性双重抑制剂 |
(Z)-3-(3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide |
1207293-36-4 |
C29H28N4O2 |
|
BI(甲基硒)乙炔 |
bi(methylseleno)acetylene |
62943-62-8 |
C4H6Se2 |
|
BHQ-1酸,BHQ-1ACID |
BHQ-1 carboxylic acid |
1190431-95-8 |
C26H28N6O5 |
|
BHQ-1氨基 |
BHQ-1 amine |
1308657-79-5 |
C25H29N7O3 |
|
BG45,一个HDACI型抑制剂,选择性抑制HDAC3 |
BG45 |
926259-99-6 |
C11H10N4O |
|
BEZ235 对甲苯磺酸盐 |
2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate salt |
1028385-32-1 |
C7H8O3S*C30H23N5O |
|
BET溴区抑制剂(CPI-0610) |
2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
1380087-89-7 |
C20H16ClN3O2 |
|
BETRIXABAN中间体 |
4-(N,N-dimethylcarbamimidoyl)benzoic acid |
244257-76-9 |
C10H12N2O2 |
|
BETA淀粉样蛋白片段1-40 |
Human beta-amyloid peptide (1-40) |
131438-79-4 |
C194H295N53O58S |
|
BETA2-澳洲茄边碱 |
L-Rhamnopyranosyl-14-D-glucopyranose solasodine |
32449-98-2 |
C39H63NO11 |
|
BETA-雌二醇 3-硫酸钠盐 |
(17β)-3-(sulfooxy)estra-1,3,5(10)-trien-17-ol sodium salt |
4999-79-5 |
C18H23O5S*Na |
|
BETA-萘乙酸甲酯 |
methyl 2-naphthylacetate |
2876-71-3 |
C13H12O2 |
|
BETA-胡萝卜素 |
Perhydro-β-carotin |
17161-33-0 |
C40H78 |
|
BETA-育亨宾 |
(+/-)-β-yohimbine |
549-84-8 |
C21H26N2O3 |
|
BETA-羟基乙基氟灭酸酯 |
2-(3-Trifluoromethyl-phenylamino)-benzoic acid 2-hydroxy-ethyl ester |
32508-98-8 |
C16H14F3NO3 |
|